CLINICAL_TRIALS
trial_result
· 2023-01-05
Clinical Trial Update: Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma [Phase 3]
Summary
Phase 3 trial update for Metvix PDT in high-risk basal cell carcinoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Basal Cell Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2023-01-05